LETTERS IN DRUG DESIGN & DISCOVERY, cilt.18, sa.1, ss.3-15, 2021 (SCI-Expanded)
Background: Due to the increasing number of cases of invasive fungal infections (IFIs), there is an urgent need to identify potent antifungal agents capable of combating IFIs. Pyrazolines are one such class of therapeutically active agents that could be considered to fulfill this need.